Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$59.24 USD
-0.26 (-0.44%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $59.26 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 1.00 |
EPS Last Quarter | 0.91 |
Last EPS Surprise | 16.67% |
ABR | 1.80 |
Earnings ESP
|
-2.68% |
---|---|
Current Year | 3.93 |
Next Year | 4.78 |
EPS (TTM) | 3.27 |
P/E (F1) | 15.13 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 250.71M | 304.80M | 976.02M | 1.15B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 252.46M | 337.81M | 988.30M | 1.18B |
Low Estimate | 247.19M | 289.20M | 963.63M | 1.13B |
Year ago Sales | 216.03M | 230.04M | 829.25M | 976.02M |
Year over Year Growth Est. | 16.05% | 32.50% | 17.70% | 17.56% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.00 | 1.29 | 3.93 | 4.78 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 0.97 | 1.16 | 3.83 | 4.57 |
High Estimate | 1.05 | 1.47 | 4.10 | 5.12 |
Low Estimate | 0.95 | 1.12 | 3.77 | 4.57 |
Year ago EPS | 0.75 | 0.82 | 2.77 | 3.93 |
Year over Year Growth Est. | 33.33% | 57.32% | 41.88% | 21.50% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 3 | 2 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.00 | 1.29 | 3.93 | 4.78 |
7 Days Ago | 1.00 | 1.29 | 3.93 | 4.78 |
30 Days Ago | 0.99 | 1.29 | 3.90 | 4.76 |
60 Days Ago | 1.05 | 1.28 | 3.90 | 4.81 |
90 Days Ago | 1.05 | 1.28 | 3.90 | 4.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.97 | 1.16 | 3.83 | 4.57 |
Zacks Consensus Estimate | 1.00 | 1.29 | 3.93 | 4.78 |
Earnings ESP | -2.68% | -9.80% | -2.59% | -4.33% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.91 | 0.79 | 0.82 | 0.75 | NA |
Estimate | 0.78 | 0.69 | 0.82 | 0.71 | NA |
Difference | 0.13 | 0.10 | 0.00 | 0.04 | 0.07 |
Surprise | 16.67% | 14.49% | 0.00% | 5.63% | 9.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more